Main Session
Sep
28
PQA 02 - Lung Cancer/Thoracic Malignancies, Patient Reported Outcomes/QoL/Survivorship, Pediatric Cancer
2412 - Screening of the Population Benefiting from Postoperative Radiotherapy in Resectable Stage III-N2 NSCLC Patients Receiving Neoadjuvant Chemoimmunotherapy
Presenter(s)
Min Li, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan,